Defensible Cancer Relevance: Building Consistency Into Every Decision

How standardized workflows, documented decision-making, and technology-assisted review can strengthen CCSG reporting.

One of the most challenging aspects of Cancer Center Support Grant (CCSG) reporting isn't collecting the data — it's making consistent decisions about what belongs in it.

Determining whether a grant, publication, or project is cancer relevant often requires professional judgment. Some records are clearly within scope; others fall into a gray area. Without a standardized approach, similar records may be classified differently depending on who reviews them, when they're reviewed, or how they're interpreted.

These inconsistencies create reporting discrepancies, reduce confidence in institutional data, and become difficult to explain during a CCSG site visit.

Key takeaway. The goal isn't to eliminate judgment — it's to make that judgment consistent, transparent, and defensible.

Start with a standardized rubric

Every institution should establish a clear cancer-relevance policy that defines how records are evaluated. Rather than relying on subjective decisions or informal discussions, use standardized percentage tiers — such as 0%, 25%, 50%, 75%, and 100% — with written criteria describing what each level represents.

A shared rubric helps ensure reviewers evaluate similar records in similar ways, while providing a framework that can be consistently applied and defended over time.

• Define standardized percentage tiers.
• Document the criteria for each level.
• Review and update your rubric regularly.

Build a structured review process

Cancer relevance should never depend on a single person's opinion. A structured review process creates checks and balances by assigning each decision to the appropriate level of review. For many institutions, that means an administrative first pass, followed by scientific or program-leadership review before records are finalized for reporting.

This approach improves consistency, distributes responsibility appropriately, and gives leadership confidence that decisions have been thoughtfully reviewed.

1. Administrative review
2. Program-leadership review
3. Scientific review (if needed)
4. Reporting-ready

Document the "why"

A cancer-relevance determination is only as strong as the rationale behind it. Capturing reviewer comments and supporting justification at the time of the decision creates valuable institutional memory. Months — or even years — later, your team can understand why a record received a particular designation without relying on email threads or individual recollection.

Best practice: document decisions when they're made — not months later during CCSG preparation.

Use technology to assist — not replace — human judgment

Keyword matching and automated suggestions can significantly reduce the time required to review large numbers of publications and awards. But technology should support reviewers — not make decisions for them.

A well-maintained cancer-relevance dictionary can identify records that may warrant review while allowing experts to evaluate borderline cases using scientific context.

Separate pending reviews from reporting-ready data

One of the most common causes of inconsistent reporting is mixing records that are still under review with those that have already been approved.

Institutions should clearly distinguish between items pending evaluation and those finalized for reporting. This ensures dashboards, CCSG data tables, and leadership reports are built from validated information — not work still in progress.

Research Logix in practice

Research Logix turns cancer relevance from an informal, spreadsheet-driven process into a standardized institutional workflow built for transparency, consistency, and audit readiness.

• Standardized rubrics — configure institution-specific cancer-relevance scoring tiers that align with your review policies.
• Structured review workflows — route publications and funding records through configurable administrative and scientific review before they're approved for reporting.
• Decision history — capture reviewer comments and rationale directly within each record, creating a permanent audit trail that supports future CCSG renewals and leadership transitions.
• Keyword-assisted review — use configurable cancer-relevance dictionaries to surface records that may need review while final determinations stay with institutional experts.
• Reporting-ready data — separate pending reviews from approved records so dashboards and CCSG metrics always reflect validated information.

Build a more defensible review process

Research Logix helps cancer centers replace manual, inconsistent review with standardized workflows that improve transparency, strengthen governance, and simplify CCSG reporting.

Schedule a demo · Contact our team